Cytori Therapeutics (CYTX) Amends and Extends Distribution Rights with GE Healthcare

September 16, 2010 8:45 AM EDT
Cytori Therapeutics, Inc. (Nasdaq: CYTX) announced that it has extended the term and modified the focus of its distribution agreement with GE Healthcare.

GE now has rights to sell select CYTX research in select European markets.

CYTX has co-exclusive sales rights into the research markets while retaining primary rights to sell into all clinical markets. The term of this agreement has been extended through the end of 2011.

Click here for details of the agreement.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News

Add Your Comment